Michael K. Manion

617 total citations
14 papers, 529 citations indexed

About

Michael K. Manion is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael K. Manion has authored 14 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael K. Manion's work include RNA Interference and Gene Delivery (4 papers), Cell death mechanisms and regulation (4 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). Michael K. Manion is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Cell death mechanisms and regulation (4 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). Michael K. Manion collaborates with scholars based in United States, Switzerland and South Africa. Michael K. Manion's co-authors include David M. Hockenbery, Jason O’Neill, Brendan C. Maguire, J. Edwin Blalock, Matteo Villain, Kristine M. Kim, Kam Y. J. Zhang, Zhengchang Su, Deborah E. Banker and Ian R. Sweet and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and The FASEB Journal.

In The Last Decade

Michael K. Manion

14 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael K. Manion United States 12 397 74 57 47 45 14 529
Julian Vasilescu Canada 11 466 1.2× 77 1.0× 72 1.3× 54 1.1× 44 1.0× 14 642
Yasushi Kondo United States 15 909 2.3× 69 0.9× 70 1.2× 47 1.0× 52 1.2× 27 1.1k
James I. Fells United States 18 717 1.8× 64 0.9× 59 1.0× 81 1.7× 24 0.5× 27 848
Sarah Amodei Italy 7 395 1.0× 68 0.9× 47 0.8× 79 1.7× 40 0.9× 8 495
Ireos Filipuzzi Switzerland 13 687 1.7× 74 1.0× 36 0.6× 54 1.1× 41 0.9× 21 897
Verena Paulitschke Austria 15 291 0.7× 126 1.7× 92 1.6× 28 0.6× 56 1.2× 29 539
Ellin‐Kristina Hillert Sweden 8 279 0.7× 106 1.4× 35 0.6× 70 1.5× 20 0.4× 8 418
Róbert Alföldi Hungary 11 205 0.5× 48 0.6× 59 1.0× 48 1.0× 26 0.6× 15 364
Edward Pichinuk Israel 12 245 0.6× 52 0.7× 42 0.7× 73 1.6× 29 0.6× 22 422
Tanya L. Wallace United States 10 293 0.7× 89 1.2× 32 0.6× 61 1.3× 70 1.6× 11 479

Countries citing papers authored by Michael K. Manion

Since Specialization
Citations

This map shows the geographic impact of Michael K. Manion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael K. Manion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael K. Manion more than expected).

Fields of papers citing papers by Michael K. Manion

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael K. Manion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael K. Manion. The network helps show where Michael K. Manion may publish in the future.

Co-authorship network of co-authors of Michael K. Manion

This figure shows the co-authorship network connecting the top 25 collaborators of Michael K. Manion. A scholar is included among the top collaborators of Michael K. Manion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael K. Manion. Michael K. Manion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Schwartz, Pamela S., et al.. (2007). 2-Methoxy antimycin reveals a unique mechanism for Bcl-xL inhibition. Molecular Cancer Therapeutics. 6(7). 2073–2080. 40 indexed citations
2.
Manion, Michael K., et al.. (2006). Small-molecule inhibitors of Bcl-2.. PubMed. 7(12). 1077–84. 16 indexed citations
3.
O’Neill, Jason, Michael K. Manion, Brendan C. Maguire, & David M. Hockenbery. (2005). BCL-XL Dimerization by Three-dimensional Domain Swapping. Journal of Molecular Biology. 356(2). 367–381. 80 indexed citations
4.
O’Neill, Jason, et al.. (2004). Promises and challenges of targeting Bcl-2 anti-apoptotic proteins for cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1705(1). 43–51. 72 indexed citations
5.
Manion, Michael K., et al.. (2004). Bcl-XL Mutations Suppress Cellular Sensitivity to Antimycin A. Journal of Biological Chemistry. 279(3). 2159–2165. 65 indexed citations
7.
Manion, Michael K. & David M. Hockenbery. (2003). Targeting Bcl-2 Related Proteins in Cancer Therapy. Cancer Biology & Therapy. 2(sup1). 104–113. 79 indexed citations
8.
Manion, Michael K. & David M. Hockenbery. (2003). TARGETING BCL-2-RELATED PROTEINS IN CANCER THERAPY. CANCER BIOL THER. 2(41). 8 indexed citations
9.
Hockenbery, David M., et al.. (2002). Mitochondria and apoptosis: New therapeutic targets. Advances in cancer research. 85. 203–242. 46 indexed citations
10.
Folkerts, Gert, Thea Leusink-Muis, Henk J. van der Linde, et al.. (2001). Calcium sensors as new therapeutic targets for airway hyperresponsiveness and asthma. The FASEB Journal. 15(10). 1831–1833. 17 indexed citations
11.
Manion, Michael K., et al.. (2000). Cellular Uptake and in Situ Binding of a Peptide Agonist for Calmodulin. Biochemical and Biophysical Research Communications. 277(2). 462–469. 8 indexed citations
12.
Villain, Matteo, Patricia L. Jackson, Michael K. Manion, et al.. (2000). De Novo Design of Peptides Targeted to the EF Hands of Calmodulin. Journal of Biological Chemistry. 275(4). 2676–2685. 50 indexed citations
13.
Manion, Michael K., Zhengchang Su, Matteo Villain, & J. Edwin Blalock. (2000). A new type of Ca 2+ channel blocker that targets Ca 2+ sensors and prevents Ca 2+ ‐mediated apoptosis. The FASEB Journal. 14(10). 1297–1306. 16 indexed citations
14.
Manion, Michael K.. (2000). A new type of Ca2+ channel blocker that targets Ca2+ sensors and prevents Ca2+-mediated apoptosis. The FASEB Journal. 14(10). 1297–1306. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026